Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹5,967 Cr₹5,819 Cr₹4,546 Cr₹4,689 Cr₹4,201 Cr

What is the latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹5,967 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹5,967 Cr
Mar2024₹5,819 Cr
Mar2023₹4,546 Cr
Mar2022₹4,689 Cr
Mar2021₹4,201 Cr

How is Total Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2025 ₹5,967 Cr
2.55
Mar2024 ₹5,819 Cr
27.99
Mar2023 ₹4,546 Cr
-3.05
Mar2022 ₹4,689 Cr
11.63
Mar2021 ₹4,201 Cr -

Compare Total Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,438.6 Cr 2.6% -0.7% 2.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -2.6% 2.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹221,666.0 Cr 6.5% 23.3% 25.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,108.0 Cr 2.6% 3% 33.5% Stock Analytics
CIPLA ₹117,139.0 Cr -1.1% -0.2% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,990.9 Cr 2.6% -13.3% -10.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

2.6%

-0.7%

2.9%

SENSEX

1.2%

0.4%

-2.9%


You may also like the below Video Courses